Nanoparticle-enhanced proton beam immunoradiotherapy drives immune activation and durable tumor rejection

The combination of radiation therapy (RT) and immunotherapy has emerged as a promising treatment option in oncology. Historically, x-ray radiation (XRT) has been the most commonly used form of RT. However, proton beam therapy (PBT) is gaining recognition as a viable alternative, as it has been shown...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Yun, Paris, Sébastien, Sahoo, Narayan, Bertolet, Genevieve, Wang, Qi, Wang, Qianxia, Barsoumian, Hampartsoum B., Da Silva, Jordan, Huang, Ailing, Doss, Denaha J., Pollock, David P., Hsu, Ethan, Selene, Nanez, Leyton, Claudia S. Kettlun, Voss, Tiffany A., Masrorpour, Fatemeh, Ganjoo, Shonik, Leuschner, Carola, Pietz, Jordan T., Puebla-Osorio, Nahum, Gandhi, Saumil, Nguyen, Quynh-Nhu, Wang, Jing, Cortez, Maria Angelica, Welsh, James W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Clinical Investigation 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10371249/
https://www.ncbi.nlm.nih.gov/pubmed/37345658
http://dx.doi.org/10.1172/jci.insight.167749

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10371249/
https://www.ncbi.nlm.nih.gov/pubmed/37345658
http://dx.doi.org/10.1172/jci.insight.167749

Ejemplares similares